P L Whitlow

Summary

Affiliation: Cleveland Clinic Foundation
Country: USA

Publications

  1. ncbi Drug-eluting stents
    Patrick Whitlow
    Interventional Cardiology, Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Desk F25, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    J Invasive Cardiol 16:2S-6S. 2004
  2. ncbi Initial experience with a dedicated coronary re-entry device for revascularization of chronic total occlusions
    Patrick L Whitlow
    Cleveland Clinic, Cleveland, Ohio 44195, USA
    Catheter Cardiovasc Interv 80:807-13. 2012
  3. ncbi Use of a novel crossing and re-entry system in coronary chronic total occlusions that have failed standard crossing techniques: results of the FAST-CTOs (Facilitated Antegrade Steering Technique in Chronic Total Occlusions) trial
    Patrick L Whitlow
    Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio 44195, USA
    JACC Cardiovasc Interv 5:393-401. 2012
  4. ncbi Acute and 12-month results with catheter-based mitral valve leaflet repair: the EVEREST II (Endovascular Valve Edge-to-Edge Repair) High Risk Study
    Patrick L Whitlow
    Cleveland Clinic, Ohio 44195, USA
    J Am Coll Cardiol 59:130-9. 2012
  5. ncbi Relationship of extent of revascularization with angina at one year in the Bypass Angioplasty Revascularization Investigation (BARI)
    P L Whitlow
    Department of Cardiology, The Cleveland Clinic Foundation, Ohio 44195, USA
    J Am Coll Cardiol 34:1750-9. 1999
  6. ncbi Results of the study to determine rotablator and transluminal angioplasty strategy (STRATAS)
    P L Whitlow
    Department of Cardiology, The Cleveland Clinic Foundation, Ohio 44195, USA
    Am J Cardiol 87:699-705. 2001
  7. ncbi One-year results of percutaneous myocardial revascularization for refractory angina pectoris
    Patrick L Whitlow
    Department of Cardiology, F25, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Am J Cardiol 91:1342-6. 2003
  8. ncbi Carotid artery stenting protected with an emboli containment system
    Patrick L Whitlow
    Department of Cardiology, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Stroke 33:1308-14. 2002
  9. ncbi Contemporary percutaneous treatment of unprotected left main coronary stenoses: initial results from a multicenter registry analysis 1994-1996
    S G Ellis
    The Cleveland Clinic Foundation, Ohio 44195, USA
    Circulation 96:3867-72. 1997
  10. ncbi The importance of proteinuria as a determinant of mortality following percutaneous coronary revascularization in diabetics
    S P Marso
    Department of Cardiology, Cleveland Clinic Foundation, Ohio 44195, USA
    J Am Coll Cardiol 33:1269-77. 1999

Collaborators

Detail Information

Publications36

  1. ncbi Drug-eluting stents
    Patrick Whitlow
    Interventional Cardiology, Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Desk F25, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    J Invasive Cardiol 16:2S-6S. 2004
    ..In optimal lesions, they may eliminate restenosis completely. Drug-eluting stents have made percutaneous intervention a safe and definitive treatment for coronary artery disease...
  2. ncbi Initial experience with a dedicated coronary re-entry device for revascularization of chronic total occlusions
    Patrick L Whitlow
    Cleveland Clinic, Cleveland, Ohio 44195, USA
    Catheter Cardiovasc Interv 80:807-13. 2012
    ..The aim of this registry was to evaluate a new device designed to facilitate antegrade guidewire re-entry into the true lumen of a chronic total coronary occlusion (CTO) from the adjacent subintimal space...
  3. ncbi Use of a novel crossing and re-entry system in coronary chronic total occlusions that have failed standard crossing techniques: results of the FAST-CTOs (Facilitated Antegrade Steering Technique in Chronic Total Occlusions) trial
    Patrick L Whitlow
    Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio 44195, USA
    JACC Cardiovasc Interv 5:393-401. 2012
    ..This study sought to examine the efficacy and safety of 3 novel devices to recanalize coronary chronic total occlusions (CTOs)...
  4. ncbi Acute and 12-month results with catheter-based mitral valve leaflet repair: the EVEREST II (Endovascular Valve Edge-to-Edge Repair) High Risk Study
    Patrick L Whitlow
    Cleveland Clinic, Ohio 44195, USA
    J Am Coll Cardiol 59:130-9. 2012
    ....
  5. ncbi Relationship of extent of revascularization with angina at one year in the Bypass Angioplasty Revascularization Investigation (BARI)
    P L Whitlow
    Department of Cardiology, The Cleveland Clinic Foundation, Ohio 44195, USA
    J Am Coll Cardiol 34:1750-9. 1999
    ....
  6. ncbi Results of the study to determine rotablator and transluminal angioplasty strategy (STRATAS)
    P L Whitlow
    Department of Cardiology, The Cleveland Clinic Foundation, Ohio 44195, USA
    Am J Cardiol 87:699-705. 2001
    ..Operator technique reflected by an rpm decrease of >5,000 from baseline is associated with CK-MB elevation and restenosis...
  7. ncbi One-year results of percutaneous myocardial revascularization for refractory angina pectoris
    Patrick L Whitlow
    Department of Cardiology, F25, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Am J Cardiol 91:1342-6. 2003
  8. ncbi Carotid artery stenting protected with an emboli containment system
    Patrick L Whitlow
    Department of Cardiology, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Stroke 33:1308-14. 2002
    ..Fear of distal embolization and stroke has aroused concern regarding carotid stenting. Devices to protect the cerebral circulation may make carotid stenting safer...
  9. ncbi Contemporary percutaneous treatment of unprotected left main coronary stenoses: initial results from a multicenter registry analysis 1994-1996
    S G Ellis
    The Cleveland Clinic Foundation, Ohio 44195, USA
    Circulation 96:3867-72. 1997
    ..Selected single-center reports suggest that the results of percutaneous intervention may now approach those of CABG...
  10. ncbi The importance of proteinuria as a determinant of mortality following percutaneous coronary revascularization in diabetics
    S P Marso
    Department of Cardiology, Cleveland Clinic Foundation, Ohio 44195, USA
    J Am Coll Cardiol 33:1269-77. 1999
    ..The aims of this study were to compare mortality and clinical events following percutaneous coronary intervention (PCI) between nondiabetics and diabetics with and without proteinuria...
  11. ncbi Relation between lesion characteristics and risk with percutaneous intervention in the stent and glycoprotein IIb/IIIa era: An analysis of results from 10,907 lesions and proposal for new classification scheme
    S G Ellis
    Department of Cardiology, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Circulation 100:1971-6. 1999
    ..Major advances in treatment options would suggest that this scheme may be outmoded, but the schemes that have been suggested to update lesion classification have not been widely accepted...
  12. ncbi Prognostic value of absolute versus relative measures of the procedural result after successful coronary stenting: importance of vessel size in predicting long-term freedom from target vessel revascularization
    K M Ziada
    Department of Cardiology, Cleveland Clinic Foundation, OH, USA
    Am Heart J 141:823-31. 2001
    ..This emphasizes the role of the vessel size as the limiting factor in determining the long-term outcome of coronary stenting...
  13. ncbi beta-blockers before percutaneous coronary intervention do not attenuate postprocedural creatine kinase isoenzyme rise
    S G Ellis
    Department of Cardiology, The Cleveland Clinic Foundation, Cleveland, Ohio, USA
    Circulation 104:2685-8. 2001
    ..The cogency of such a conclusion is dependent on the ability to risk-adjust for the multiple differences in patients treated with and without BBs...
  14. ncbi Evidence that angiotensin-converting enzyme inhibitor use diminishes the need for coronary revascularization after stenting
    Stephen G Ellis
    Department of Cardiology, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Am J Cardiol 89:937-40. 2002
    ..06, p = 0.33), which is consistent with the results of prior randomized trials. ACE inhibitors appear to decrease late revascularization, possibly due to a reduction in restenosis after coronary stenting...
  15. ncbi Medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease
    Mark A Hlatky
    Stanford University School of Medicine, HRP Redwood Building, Room 150, Stanford, CA 94305 5405, USA
    Circulation 110:1960-6. 2004
    ..Coronary bypass surgery (CABG) and angioplasty (PTCA) have been compared in several randomized trials, but data about long-term economic and quality-of-life outcomes are limited...
  16. ncbi Impact of female sex on outcome after percutaneous coronary intervention
    John H Chiu
    Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Am Heart J 148:998-1002. 2004
    ..However, there is a greater incidence of post-procedural bleeding complications among women...
  17. ncbi Leukocyte count predicts microembolic Doppler signals during carotid stenting: a link between inflammation and embolization
    Herbert D Aronow
    Michigan Heart PC, 5325 Elliott Dr, Ypsilanti, MI 48197, USA
    Stroke 36:1910-4. 2005
    ..Distal microembolization occurs invariably during carotid stenting. Little is known about the relationship between systemic inflammation and embolization during carotid stenting...
  18. ncbi Correlates and outcomes of retroperitoneal hemorrhage complicating percutaneous coronary intervention
    Stephen G Ellis
    Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, Ohio 44195, USA
    Catheter Cardiovasc Interv 67:541-5. 2006
    ..Retroperitoneal hemorrhage (RPH) is an infrequent but occasionally fatal complication of percutaneous coronary intervention (PCI). Therefore, it has been studied in relatively small numbers of patients...
  19. ncbi Preprocedural statin use is associated with a reduced hazard of postprocedural myonecrosis in patients undergoing rotational atherectomy--a propensity-adjusted analysis
    Hitinder S Gurm
    Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, OH, USA
    Am Heart J 151:1031.e1-6. 2006
    ..1% vs 52.3%, P < .001) or significant myonecrosis (7.5% vs 21.8%, P < .001) was significantly lower among patients pretreated with statins. This difference remained significant after multivariable and propensity adjustment...
  20. ncbi Images in vascular medicine. Acute aortic intramural hematoma associated with severe bilateral renal artery stenosis
    Heather L Gornik
    Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, 9500 Euclid Avenue - Desk S60, Cleveland, OH 44195, USA
    Vasc Med 11:268-70. 2006
  21. ncbi Real-world bare metal stenting: identification of patients at low or very low risk of 9-month coronary revascularization
    Stephen G Ellis
    Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Catheter Cardiovasc Interv 63:135-40. 2004
    ..Conversely, if the benefits of DESs are attenuated in routine practice, many groups of patients treated with BMSs may have nearly comparable results...
  22. ncbi Native coronary disease progression exceeds failed revascularization as cause of angina after five years in the Bypass Angioplasty Revascularization Investigation (BARI)
    Edwin L Alderman
    Cardiovascular Division, Stanford University, Stanford, California, USA
    J Am Coll Cardiol 44:766-74. 2004
    ..Coronary angiograms obtained five years following revascularization were examined to assess the extent of compromise in myocardial perfusion due to failure of revascularization versus progression of native disease...
  23. ncbi A prospective, multicenter, randomized trial of percutaneous transmyocardial laser revascularization in patients with nonrecanalizable chronic total occlusions
    Gregg W Stone
    Cardiovascular Research Foundation, New York, New York 10021, USA
    J Am Coll Cardiol 39:1581-7. 2002
    ..We sought to evaluate the safety and efficacy of percutaneous transmyocardial revascularization (PTMR) in patients with refractory angina caused by one or more chronic total occlusions (CTOs) of a native coronary artery...
  24. ncbi Death following creatine kinase-MB elevation after coronary intervention: identification of an early risk period: importance of creatine kinase-MB level, completeness of revascularization, ventricular function, and probable benefit of statin therapy
    Stephen G Ellis
    Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Circulation 106:1205-10. 2002
    ..Creatine kinase (CK)-MB elevation after percutaneous coronary intervention (PCI) has been associated with subsequent cardiac death. The patients at risk, the timing of risk, and potential treatment implications are uncertain...
  25. ncbi Emergency coronary artery bypass surgery in the contemporary percutaneous coronary intervention era
    Niranjan Seshadri
    Department of Cardiology, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Circulation 106:2346-50. 2002
    ..Risk factors include female sex and a higher ACC/AHA score of the intervened lesion. However, morbidity and mortality of emergency CABG remain high even in the new millennium...
  26. ncbi Effect of uncoated stenting versus balloon angioplasty alone of long coronary (>20 mm) versus shorter narrowings on one-year event-free survival
    Fernando A Cura
    Department of Cardiology, Instituto Cardiovascular de Buenos Aires, Argentina
    Am J Cardiol 91:587-90. 2003
  27. ncbi Influence of various percutaneous coronary interventional devices on postinterventional luminal shape and plaque surface characteristics as determined by intravascular ultrasound
    Berkten Berkalp
    Department of Cardiology, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Am J Cardiol 91:1269-72. 2003
  28. ncbi Effects of long-term prednisone (> or =5 mg) use on outcomes and complications of percutaneous coronary intervention
    Stephen G Ellis
    Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, 9500 Euclid Avenue, F 25, Cleveland, OH 44195, USA
    Am J Cardiol 93:1389-90, A6. 2004
    ..Steroid use was not associated with increased risk of composite major ischemia events but was associated with a threefold risk (p = 0.01) of major vascular complications and a three- to fourfold risk (p = 0.026) of coronary perforation...
  29. ncbi Peripheral vascular disease and one-year mortality following percutaneous coronary revascularization
    John H Chiu
    Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Am J Cardiol 92:582-3. 2003
    ..After adjustments in a multivariate model, a history of peripheral vascular disease was found to be associated with a two- to threefold increase in mortality at 1 year after coronary stent placement...
  30. ncbi Impact of mitral regurgitation on long-term survival after percutaneous coronary intervention
    Stephen G Ellis
    Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Am J Cardiol 89:315-8. 2002
  31. ncbi 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evidence an
    Spencer B King
    Circulation 117:261-95. 2008
  32. ncbi 2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines
    Spencer B King
    J Am Coll Cardiol 51:172-209. 2008
  33. ncbi Development of coronary aneurysm after drug-eluting stent implantation
    Anthony A Bavry
    Ann Intern Med 146:230-2. 2007
  34. ncbi Differential influence of diabetes mellitus on increased jeopardized myocardium after initial angioplasty or bypass surgery: bypass angioplasty revascularization investigation
    Kevin E Kip
    Department of Epidemiology, University of Pittsburgh, Pittsburgh, PA 15261, USA
    Circulation 105:1914-20. 2002
    ..Importantly, diabetes mellitus may differentially influence long-term survival after PTCA or CABG...
  35. ncbi The impact of body mass index on short- and long-term outcomes inpatients undergoing coronary revascularization. Insights from the bypass angioplasty revascularization investigation (BARI)
    Hitinder S Gurm
    Cleveland Clinic Foundation, Cleveland, Ohio, USA
    J Am Coll Cardiol 39:834-40. 2002
    ....
  36. ncbi Long-term impact of drug-eluting stents versus bare-metal stents on all-cause mortality
    Mehdi H Shishehbor
    Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio 44195, USA
    J Am Coll Cardiol 52:1041-8. 2008
    ..Our purpose was to examine the incidence of all-cause mortality among drug-eluting stents (DES) and bare-metal stents (BMS) while adjusting for many confounding factors generally not considered in prior studies...